Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123409533 | 12340953 | 3 | F | 20160711 | 20160506 | 20160715 | EXP | US-PFIZER INC-2016247262 | PFIZER | 26.00 | YR | F | Y | 104.00000 | KG | 20160715 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123409533 | 12340953 | 1 | PS | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, DAILY | Y | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | ||||||
| 123409533 | 12340953 | 2 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | QD | ||||||||
| 123409533 | 12340953 | 3 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123409533 | 12340953 | 1 | Depression |
| 123409533 | 12340953 | 2 | Attention deficit/hyperactivity disorder |
| 123409533 | 12340953 | 3 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123409533 | 12340953 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123409533 | 12340953 | Abdominal discomfort | |
| 123409533 | 12340953 | Condition aggravated | |
| 123409533 | 12340953 | Depression | |
| 123409533 | 12340953 | Drug ineffective | |
| 123409533 | 12340953 | Headache | |
| 123409533 | 12340953 | Hyperhidrosis | |
| 123409533 | 12340953 | Mood altered | |
| 123409533 | 12340953 | Pyrexia | |
| 123409533 | 12340953 | Sleep disorder | |
| 123409533 | 12340953 | Suicidal ideation | |
| 123409533 | 12340953 | Vomiting | |
| 123409533 | 12340953 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123409533 | 12340953 | 2 | 2008 | 0 | ||
| 123409533 | 12340953 | 3 | 2006 | 0 |